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ABSTRACT
In order for the global healthcare system to
remain sustainable, healthcare spending needs
to be reduced, and self-treating certain
conditions under the guidance of a pharmacist
provides a means of accomplishing this goal.
This article was developed to describe global
healthcare trends affecting self-care with a
specific focus on the role of the pharmacist in
facilitating over-the-counter (OTC) medication
management. Potential healthcare-related
economic benefits associated with the self-care
model are outlined. The importance of the
collaboration between healthcare providers
(HCPs), including specialists, primary care
providers, and pharmacists, is also discussed.
The evolving role of the pharmacist is examined
and recommendations are provided for ways to
successfully engage with other HCPs and
consumers to optimize the pharmacist’s
unique qualifications and accessibility in the
community. Using the management of frequent
heartburn with an OTC proton-pump inhibitor
as a model, the critical role of the pharmacist in
patient self-treatment of certain symptoms will
be discussed based on the World
Gastroenterology Organization’s recently
published guidelines for the community-based
management of common gastrointestinal
symptoms. As the global healthcare system
continues to evolve, self-care is expected to
have an increasing role in treating certain
minor ailments, and pharmacists are at the
forefront of these changes. Pharmacists can
guide individuals in making healthy lifestyle
choices, recommend appropriate OTC
medications, and educate consumers about
when they should consult a physician.
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INTRODUCTION
The global healthcare system is expected to
undergo significant changes in the coming
decades to remain economically viable, and
self-care and self-medication will likely become
important for driving these changes. The
authors, who provided the concept and
developed the content for this review, are
experts in the area of self-care and describe
the various and related aspects of this
treatment model, as well as the role of
self-care in the future of the global healthcare
system.
John Bell, AM, BPharm, FPS, FRPharmS,
FACPP, MSHP, the Principal Advisor to the
Pharmaceutical Society of Australia’s Self-Care
Program, has authored Importance of Self-Care
in the Future of Quality Affordable Medicine in
the Twenty First Century, which defines
self-care and describes its key stakeholders
and components, including the importance
of enhancing health literacy. The potential
financial savings of shifting from
physician-based care to self-care is also
discussed. Additionally, Mr. Bell discusses
The Role of the Pharmacist in Self-Care: A
Prescription for the Future. Because pharmacists
are ideally placed to provide healthcare
advice, the pharmacist’s role as healthcare
provider (HCP) will continue to expand.
Pharmacists not only fill prescriptions but
also educate consumers about the
importance of healthy lifestyle choices,
recommend over-the-counter (OTC)
treatments, perform medication monitoring,
and refer consumers to physicians as
necessary.
Gerald Dziekan, MD, MSc, is the Director
General of the World Self-Medication Industry
whose section Why Self-Care? A Public Health
and Health Economic Perspective on the Benefits of
Self-Care describes ways that self-care, and in
particular, self-medication, can positively affect
public health and reduce the economic burden
of managing minor ailments and some chronic
conditions by shifting care to the consumer
with guidance from pharmacists and
physicians.
Varocha Mahachai, MD, FRCP, is the
Director of the Gastrointestinal & Liver Center
for Bangkok Medical Center and Professor at
Chulalongkorn University. Her section, Reflux
and Heartburn as a Self-Care Model, describes the
number of OTC treatments available for
treating acid reflux-related symptoms,
including recent switches of proton-pump
inhibitors (PPIs) from prescription to OTC.
With these readily available treatments,
pharmacists can help consumers effectively
and safely manage their acid reflux-related
symptoms. Pharmacists can also help limit the
risk for heartburn treatments masking more
serious underlying conditions.
Within different sections, this article
describes factors affecting the global
healthcare system, and through examples such
as the increasing availability of OTC PPIs also
describes the roles that self-care and
pharmacists can play in sustaining the
economic viability of that system by shifting a
portion of the costs for caring for some minor
ailments to consumers.
This article is based on previously conducted
studies and does not involve any new studies of
human or animal subjects performed by any of
the authors.
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IMPORTANCE OF SELF-CARE
IN THE FUTURE OF QUALITY
AFFORDABLE MEDICINE
IN THE TWENTY FIRST CENTURY
Self-care is characterized byhealthcare consumers
who take proactive roles in identifying and
managing their health conditions to optimize
their overall physical health and psychological
and spiritual well-being [1, 2]. Self-care has been
described as existing on a continuum,withpurely
self-initiated activities such as preventative
healthy lifestyle choices on one end and
treatment for acute minor ailments and
maintenance therapy for certain chronic
conditions on the other (Fig. 1) [1, 3, 4].
Effective self-care requires active collaboration
between consumers and HCPs, including
pharmacists, and is reliant on well-informed
consumers and HCPs with effective
communication skills [5]. Consumers are
supportive of the concept of self-care, which
they view as an essential feature of their
healthcare, yet few consumers are confident that
they can effectively manage their own health [5].
Webber et al. [6] describe several key domains
and behaviors of self-care. Health literacy is a key
component of self-care and is broadly defined as
an individual’s ability to acquire and understand
information related to their healthcare. Self-care
is also reliant on an individual’s awareness of
their physical and mental health, including
awareness of their current health status (e.g.,
body mass index, cholesterol, blood pressure),
which requires receiving regular health
screenings. Self-care also involves engaging in
regular physical activity, such as moderate levels
of exercise (e.g., walking, cycling), eating a
healthy, nutritious diet with appropriate caloric
intake, and having good hygiene, including
proper dental care. In addition, effective
self-care involves avoiding and mitigating
potential health risks, such as eliminating
tobacco use, limiting alcohol consumption, and
receiving vaccinations, as well as using products,
services, diagnostics, and medicines rationally
and responsibly. These authors suggest that
identifying domains where an individual is
lacking can allow for developing a personalized

























Fig. 1 The self-care continuum [1]. Adapted with permission from the Self Care Forum of the United Kingdom
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self-care with an action plan, including
identifying areas where guidance (e.g., from an
HCP) is necessary.
Self-care is reliant on enhancing consumers’
health literacy to ensure that they can process
the health-related information that they obtain
on their own or from HCPs and allow for
making informed healthcare decisions [5, 7].
Limited health literacy is common, particularly
in those who are older, from lower
socioeconomic strata, and with limited
education [7]. Estimates in the United States
suggest that 36% of the adult population has
basic or below basic health literacy, while in
Australia it has been estimated that
approximately 60% of the population has
below the minimum health literacy necessary
to meet the demands of everyday life and work
‘‘in the emerging knowledge-based economy’’
[8, 9]. The consequences of poor health literacy
include an inability to communicate needs to
HCPs, a limited ability to understand
instructions for taking prescription medicines,
higher hospitalization rates, and, implicitly,
higher healthcare costs [7].
Self-care can contribute substantially to
easing financial pressures on the healthcare
system by shifting the cost of care for some
relevant conditions from physicians to
consumers while also enhancing healthcare
outcomes [3, 10]. Empowering pharmacists
and establishing community pharmacies that
serve as cost-effective resource centers for
providing authoritative, objective,
evidence-based information/advice and
directions for the appropriate use of various
treatments is a goal of self-care that is of interest
to consumers [11–13]. Pharmacists have a
necessary role in screening for certain
conditions, making self-care treatment
recommendations, and/or providing referral
support as needed. Programs have been
implemented to meet this goal, including the
Health Destination Pharmacy program in
Australia, which seeks to position pharmacists
as primary HCPs who emphasize self-care [13]. A
study of participants in this program reported
benefits for the pharmacy as a whole as well as
for consumers despite a minority of pharmacies
experiencing negative financial growth during
the study period. The Global Respiratory
Infection Partnership is another example of
providing appropriate self-care information
and advice through HCPs, including
pharmacists, for managing upper respiratory
tract infections (e.g., coughs, colds) without
the use of antibiotics [14]. With the increasing
incidence of antimicrobial resistance,
pharmacists can play a role in advocating
antibiotic stewardship by promoting use of
self-care treatment options. These initiatives
suggest that the expanding role of pharmacists
as HCPs, particularly within the realm of
self-care, can enhance outcomes and reduce
the cost and resource burden on the healthcare
system.
John Bell, AM, BPharm, FPS, FRPharmS,
FACPP, MSHP, Principal Advisor to the
Pharmaceutical Society of Australia’s Self-Care
Program.
THE ROLE OF THE PHARMACIST
IN SELF-CARE: A PRESCRIPTION
FOR THE FUTURE
HCPs, in particular general practitioners (GPs),
continue to be the primary source for treating
minor ailments [5]. A study conducted in the
United Kingdom (UK) reported that 13% of GP
and 5% of emergency department (ED) hours
were spent on consulting for minor ailments
that could be managed in a community
pharmacy setting [15]. In addition to
managing certain chronic conditions, self-care,
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including self-medication, can help to shift the
burden of treating these minor ailments from
GPs to other HCPs, particularly pharmacists,
and consumers themselves (Fig. 2) [3].
Pharmacists, a widely available and
conveniently accessible healthcare resource
[16], are ideally placed to meet the challenges
of ever-evolving consumer needs and global
healthcare systems [12]. In addition to
supplying treatments prescribed by physicians,
pharmacists can serve as integral partners in a
collaborative care team of HCPs [3, 12].
Pharmacists are also involved with health
promotion by screening for, and increasing
the awareness of, certain conditions and
discussing strategies such as making healthy
lifestyle choices for preventing certain health
issues [12].
Self-medication is a key component of
self-care [17]. Pharmacists provide valuable
information to ensure that consumers receive
treatments that are appropriate for a given
condition [12]. Importantly, consumers view
pharmacists as trusted resources for providing
information about their healthcare [18]. When
selecting a non-prescription medicine,
consumers report that the advice of a
pharmacist is one of the most important
factors in making their decision (Fig. 3) [18].
Although pharmacists can be the first point of
contact for some healthcare consumers, they
are a relatively underutilized resource [5].
The potential benefits of consulting a
pharmacist in the first instance include more
immediate access versus having to wait for a GP
appointment, as well as reducing travel time
and healthcare-related costs [19]. Additionally,
in many cases non-prescription/OTC products
are less expensive than prescription
medications [19], and as mentioned
previously, the pharmacist is well positioned
to refer consumers to a physician when
symptoms indicate a potentially serious
condition. A study conducted in the UK has
demonstrated that individuals seeking
treatment for minor ailments from an ED, a
GP, or a community pharmacy had comparable


















Fig. 2 Self-care pyramid [3]. From Self-Care: A Winning
Solution for Citizens, Healthcare Professionals, Health
Systems. Brussels: Association of the European
Self-Medication Industry; 2012. Adapted with permission
from the European Self-Medication Industry. GP general
practitioner
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However, the costs associated with receiving a
consultation in the pharmacy setting were
significantly lower than in the ED or GP
setting. The key factors associated with
selecting a point of care were location and
convenience and prior experience with and
perceived severity of the symptom that
necessitated seeking treatment from an HCP.
Some individuals presenting in the pharmacy
setting had previously experienced the
symptoms, as indicated by their often direct
request for a specific treatment. In contrast, the
majority of those seeking care from an ED were
experiencing the symptom for the first time and
the symptoms were perceived to be more severe.
This effect may have confounded the cost
analyses, but these data provide insights into
the types of conditions that consumers are
likely to self-treat in the pharmacy setting. A
chronological review of policy changes in the
UK suggested that continuing to reclassify
medications used and providing free access to
an HCP and free or low-cost treatment for
minor ailments will further ease the burden of
treating minor ailments in the GP setting while
increasing access to healthcare services [21].
Utilizing self-care can enhance patients’
confidence by improving their skill set and
empowering them to treat certain conditions
on their own instead of always relying on an
HCP [19]. For certain conditions, a collaborative
care model where the individual is first
diagnosed by a physician who provides an
initial treatment plan is most appropriate [3].
After the initial diagnosis, the pharmacist is
responsible for educating the consumer on
identifying signs and symptoms of recurrence
and ways to effectively self-treat these
recurrences, as well as identifying
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Fig. 3 Important factors in choosing a non-prescription
medicine [18]. Adapted from The Changing Landscape—A
Multi-Country Study Undertaken With AESGP. Nielsen
Global On-Line Omnibus Mar/Apr 2009.  2009 The
Nielsen Company. Adapted with permission
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physician again, for instance if symptom
severity increases [22]. Pharmacists are also
ideally placed to monitor for possible
interactions between the multiple treatments
that an individual may be receiving, as well as
to inform consumers about the potential
adverse events associated with a given
treatment [22].
Despite these benefits, there are some
potential concerns about self-medication,
including the potential for consumers to
inappropriately use the treatment that is
recommended [23]. There is also the concern
that some symptoms perceived to be minor may
be the result of an undetected more serious
condition that was not appropriately identified
[23]. It is, therefore, important that
undergraduate and postgraduate pharmacist
training involves ways of enhancing clinical
decision-making skills, which, as indicated by a
survey of Canadian pharmacists, are often
lacking [24].
Consumers are assuming greater autonomy
in their healthcare, which could increase the
healthcare system’s efficiency [5]. These
emerging trends lend themselves to a greater
role for self-care and expanding the role of
community pharmacies. In the future, it is most
likely pharmacies and pharmacists will not only
be providing prescription and non-prescription
medications, but will also be involved with
more complex interventions. Assisting with
self-care and self-medication is essential as the
role of the pharmacist continues to evolve to
meet the demands of the healthcare system and
to ensure they are providing a unique,
value-added service.
John Bell, AM, BPharm, FPS, FRPharmS,
FACPP, MSHP, Principal Advisor to the
Pharmaceutical Society of Australia’s Self-Care
Program.
WHY SELF-CARE? A PUBLIC HEALTH
AND HEALTH ECONOMIC
PERSPECTIVE ON THE BENEFITS
OF SELF-CARE
The aging global population [25], increasing
incidence and burden of non-communicable
diseases (NCDs), and other societal changes
(e.g., globalization) [26] have led to increases
in healthcare spending [26, 27], which can
outpace the growth in gross domestic product
[27]. NCDs, including potentially
preventable conditions such as cardiovascular
disease, respiratory disorders, cancer, and
diabetes, are associated with significant disease
burden and have become the leading causes of
global mortality [26]. Compounding the
pressure on the healthcare system, the number
of workers per retiree is decreasing, particularly
in emerging markets [28].
Traditional healthcare models characterize
consumers as limitedly involved, passive
recipients, but a shift toward empowering
patients and consumers by increasing health
literacy to enhance their participation is
occurring [5, 29]. Advice from HCPs continues
to be an important source of health-related
information, but consumers often seek out
information on their own, commonly through
on-line resources [30], which can increase their
ability to recognize symptoms/conditions
suitable for self-care. Mobile technologies are
becoming increasingly relevant to self-care by
offering new consumer education opportunities
that can reach into developing countries further
and more cost effectively than healthcare
infrastructures can [26, 31]. Importantly,
consumers who are the most confident in
making healthcare decisions have healthcare
costs that are 8–21% lower than those who are
the least confident [29].
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The various stakeholders involved in
self-care have complementary roles that must
be evaluated from their various perspectives.
The pharmaceutical industry is needed to
develop safe and effective treatments, to
identify appropriate prescription-to-OTC
switch candidates, and to educate HCPs and
consumers. Governmental agencies are needed
to establish appropriate regulations and foster
partnerships between HCPs and consumers
(e.g., through public health campaigns,
enhancing self-care initiatives). Appropriate
regulatory frameworks are needed to empower
consumers, provide access to safe and effective
treatments, promote pharmacists’ roles, and
enhance access to OTC products (e.g., by
providing tax deductions, switching
appropriate treatments from prescription to
OTC status). HCPs help consumers recognize
symptoms and identify appropriate self-care
options, including the use of OTC products.
More than 80% of physicians agree that
responsible use of OTC products can reduce
the burden on the healthcare system and
effectively manage minor ailments [32].
Pharmacists have an important role in
self-care, particularly self-medication, by
serving as a point of access for providing
treatment advice or HCP referrals as necessary.
In the UK, a study of community pharmacy
users seeking care for flu-like symptoms assessed
consumer preferences for pharmacy services
based on their willingness to pay. Respondents
reported a willingness to pay £38 to receive care
in a pharmacy setting versus no treatment [33].
However, the quality of care that was provided
had an effect on their willingness to pay, as
indicated by their unwillingness to pay for care
at the lowest-quality pharmacies. The
characteristics that differentiated high- from
low-quality pharmacies included whether a
friendly, trained pharmacy staff member
provided a better understanding of the nature
of symptoms and how to effectively manage
them. Additionally, as has been previously
reported, the convenience of accessing the
pharmacy was an important factor, as was
whether it was local or physician-affiliated
versus being located in a shopping center.
Self-care can benefit individuals, healthcare
systems, and, as such, society as a whole. The
HCP’s role is evolving toward partnering with
empowered consumers who are confident in
making healthcare decisions. Self-care not only
provides an opportunity to relieve
overburdened healthcare systems, but also
empowers patients and consumers and allows
them to more effectively manage their
conditions and improve health outcomes and
quality of life [5]. Effective use of OTC products
can eliminate the stress and inconvenience of
HCP visits, saving time and money. In
particular, evidence is growing that supports
the value OTC products add to the global
healthcare system. In addition to reducing
costs associated with unnecessary HCP visits,
self-care and the use of OTC products can
enhance health outcomes and reduce lost
work productivity (Table 1) [10, 34]. For
example, in the European Union, the
estimated annual savings from shifting 5% of
care to self-medication is over €16 billion [3].
Although these studies report estimated costs
based on hypothetical models, they indicate
that there is the potential for substantial
healthcare cost savings from enhancing the
self-care options that are available to
consumers.
Gerald Dziekan, MD, MSc, Director General,
World Self-Medication Industry.
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REFLUX AND HEARTBURN
AS A SELF-CARE MODEL
Heartburn is a common recurrent
gastroesophageal symptom marked by a burning
sensation that develops behind the sternum and
radiates up toward the neck, which may be
accompanied by regurgitation of stomach
contents (e.g., acid, food) into the mouth [35].
These symptoms most commonly occur after
meals, during exercise, and while lying
recumbently, particularly at night.
Approximately 10–20% of individuals in Western
countries experience these symptoms at least
weekly, while in Asian countries the prevalence is
often less than 5% [36]. The degree of impairment,
including symptom frequency and severity,
distinguishes frequent heartburn from
gastroesophageal reflux disease [36]. However,
frequently occurring symptoms of heartburn and
regurgitation can negatively impact the affected
individual’s quality of life [35].
The World Gastroenterology Organization
Global Guidelines for community-based
management of common gastrointestinal
symptoms provide resource-sensitive treatment
recommendations based on the point of care
[35]. According to these guidelines, the primary
goal for self-treating frequent heartburn is
complete symptomatic relief and restoring
quality of life. Self-care treatment options for
heartburn and/or regurgitation include lifestyle
and behavioral modifications such as weight
loss and limitations on the consumption of
foods/beverages and/or medications that may
exacerbate symptoms. OTC treatment options,
such as antacids, alginates, H2 receptor
antagonists (H2RAs), and PPIs, are also
recommended based on the frequency and
intensity of heartburn and regurgitation
symptoms. Antacids, alginates, and lower- and
higher-dose OTC H2RAs are appropriate for
infrequent, mild, or moderate symptoms,
while OTC PPIs are appropriate for frequent
symptoms that occur C2 days/week. Regardless
of the frequency and intensity of symptoms, all
individuals with heartburn should be instructed
to include lifestyle/behavioral modifications as
adjunctive therapies to these pharmacologic
treatments.
Table 1 Economic beneﬁts of self-care




77 billion USD 3.86 billion AUD
Drug costs 25 billion USD NA
Productivity 23 billion USD estimated savings in productivity loss 6.55 billion AUD
Total 102 billion USD
For every USD spent on OTC medicines, the US healthcare
system saves 6–7 USD in avoided costs
10.4 billion AUD
Over 4 AUD saved per dollar spent
Healthcare
system
4 billion USD estimated additional annual savings in avoided
emergency department visits
2.1 billion AUD additional savings if
11 categories of Rx were to be
switched to OTC
AUD Australian dollars, NA not available, OTC over-the-counter, Rx prescription, USD US dollars
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A treatment algorithm that was developed
for managing individuals presenting in the
pharmacy setting with self-diagnosed reflux
symptoms describes the circumstances that
warrant referral to a physician [37]. Individuals
presenting with alarm features, including new
symptom onset at over 50 years of age, painful
or difficult swallowing, gastrointestinal
bleeding, laryngitis, unexplained weight loss,
and cardiac-type chest pain, should be referred
to a physician [35, 37]. Additionally, individuals
who do not adequately respond to a 2-week
course of OTC PPI therapy and those who
experience a recurrence of symptoms within
3 months of stopping a 2-week course of OTC
PPI therapy should be referred.
The relatively high prevalence of
uncomplicated frequent heartburn and the
availability of highly effective OTC treatment
options make managing these symptoms in a
physician’s office inefficient in terms of cost
and resource utilization [37]. Pharmacists are,
therefore, ideally positioned to serve as
frontline HCPs with an important role in
identifying consumers who are suitable for
self-treating their heartburn. Additionally,
pharmacists can reinforce directions provided
by the product labelling and communicate that
a failure to respond to treatment requires a
physician consultation. Frequent heartburn has
few direct long-term consequences, but it is
important to identify those with a high
likelihood of having a serious underlying
condition to manage these symptoms
effectively and safely [35, 37]. Additionally,
although there are potential safety concerns
associated with the long-term use of PPIs,
instances are rare in this population and most
individuals experiencing frequent heartburn
will not require extended periods of treatment
[35, 37].
Varocha Mahachai, MD, FRCP, Director, GI
& Liver Center, Bangkok Medical Center,
Chulalongkorn University, Bangkok, Thailand.
CONCLUSION
Shifting care for certain conditions from
physicians to other HCPs, including
pharmacists, and consumers can help to
alleviate the increasing burden on the
healthcare system by reducing costs and
resource utilization. Self-care and
self-medication are expected to be important
aspects of the evolving global healthcare system
that will seek to manage these issues.
Self-care functions most efficiently when the
various stakeholders collaborate to serve
consumers’ needs by providing appropriate
guidance and empowering their
decision-making processes. Pharmacists,
therefore, play a critical role in helping
consumers manage minor ailments without
relying on costly and time-consuming
physician visits for conditions that can be
self-managed. Additional stakeholders,
including the pharmaceutical industry and
governmental agencies, help to ensure that
safe and effective self-care treatment options
are available.
Heartburn and regurgitation is a prime
example of a generally mild condition that is
ideal for self-care. Lifestyle modifications and
numerous OTC treatment options are available
that have been shown to be safe and effective.
Pharmacists can be expected to play a key role
in educating consumers about the proper use of
these products, including, for instance,
following label instructions and consulting a
physician if symptoms recur at the end of the
assigned treatment period or if other alarm
features appear.
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